| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000226869.2 |
Tanespimycin |
Lymphoid neoplasm diffuse large B-cell lymphoma |
0.037575765 |
Resistant |
| ENSG00000226869.2 |
Tanespimycin |
Kidney renal clear cell carcinoma |
0.038717963 |
Resistant |
| ENSG00000226869.2 |
Tanespimycin |
Lung squamous cell carcinoma |
0.002852595 |
Resistant |
